Crossmark

Next-generation sequencing in the molecular classification of endometrial carcinomas: Experience with 270 cases suggesting a potentially more aggressive clinical behavior of multiple classifier endometrial carcinomas

Crossref DOI link: https://doi.org/10.1007/s00428-024-03996-1

Published Online: 2024-12-15

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Michalova, Kvetoslava https://orcid.org/0000-0003-3231-6870
Strakova-Peterikova, Andrea

Ondic, Ondrej

Vanecek, Tomas

Michal, Michael

Hejhalova, Nikola

Holub, Petr

Slavik, Petr

Hluchy, Adam

Gettse, Polina

Daum, Ondrej

Svajdler, Marian

Michal, Michal

Presl, Jiri
Funding

Funding for this research was provided by:

Ministerstvo Školství, Mládeže a Tělovýchovy (SVV 260652)
License Information

Text and Data Mining valid from 2024-12-15

Version of Record valid from 2024-12-15
More Information

Article History

Received: 22 July 2024

Revised: 15 November 2024

Accepted: 27 November 2024

First Online: 15 December 2024

Declarations

:

: The study was approved by the Ethics Committee of the General University Hospital in Prague in compliance with the Helsinki Declaration (No. 2140/19 S-IV). The Ethics Committee waived the requirement for informed consent as according to the Czech Law (Act. no. 373/11 and its amendment Act no. 202/17); it is not necessary to obtain informed consent in fully anonymized studies.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below